ID   CLK2_HUMAN              Reviewed;         499 AA.
AC   P49760; B1AVS9; B5MBX6; Q96CQ0;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   12-OCT-2022, entry version 212.
DE   RecName: Full=Dual specificity protein kinase CLK2;
DE            EC=2.7.12.1;
DE   AltName: Full=CDC-like kinase 2;
GN   Name=CLK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=7990150; DOI=10.1006/jmbi.1994.1763;
RA   Hanes J.J., der Kammer H., Klaudiny J.J., Scheit K.H.;
RT   "Characterization by cDNA cloning of two new human protein kinases.
RT   Evidence by sequence comparison of a new family of mammalian protein
RT   kinases.";
RL   J. Mol. Biol. 244:665-672(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=9331372; DOI=10.1101/gr.7.10.1020;
RA   Winfield S.L., Tayebi N., Martin B.M., Ginns E.I., Sidransky E.;
RT   "Identification of three additional genes contiguous to the
RT   glucocerebrosidase locus on chromosome 1q21: implications for Gaucher
RT   disease.";
RL   Genome Res. 7:1020-1026(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Lung, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION.
RX   PubMed=8910305; DOI=10.1074/jbc.271.44.27299;
RA   Lee K., Du C., Horn M., Rabinow L.;
RT   "Activity and autophosphorylation of LAMMER protein kinases.";
RL   J. Biol. Chem. 271:27299-27303(1996).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, AND PHOSPHORYLATION.
RX   PubMed=9637771; DOI=10.1006/excr.1998.4083;
RA   Duncan P.I., Stojdl D.F., Marius R.M., Scheit K.H., Bell J.C.;
RT   "The Clk2 and Clk3 dual-specificity protein kinases regulate the
RT   intranuclear distribution of SR proteins and influence pre-mRNA splicing.";
RL   Exp. Cell Res. 241:300-308(1998).
RN   [7]
RP   FUNCTION.
RX   PubMed=10480872; DOI=10.1074/jbc.274.38.26697;
RA   Moeslein F.M., Myers M.P., Landreth G.E.;
RT   "The CLK family kinases, CLK1 and CLK2, phosphorylate and activate the
RT   tyrosine phosphatase, PTP-1B.";
RL   J. Biol. Chem. 274:26697-26704(1999).
RN   [8]
RP   INTERACTION WITH UBL5.
RX   PubMed=12705895; DOI=10.1016/s0006-291x(03)00549-7;
RA   Kantham L., Kerr-Bayles L., Godde N., Quick M., Webb R., Sunderland T.,
RA   Bond J., Walder K., Augert G., Collier G.;
RT   "Beacon interacts with cdc2/cdc28-like kinases.";
RL   Biochem. Biophys. Res. Commun. 304:125-129(2003).
RN   [9]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   FUNCTION, ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=19168442; DOI=10.1161/circresaha.108.183905;
RA   Eisenreich A., Bogdanov V.Y., Zakrzewicz A., Pries A., Antoniak S.,
RA   Poller W., Schultheiss H.P., Rauch U.;
RT   "Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of
RT   tissue factor in human endothelial cells.";
RL   Circ. Res. 104:589-599(2009).
RN   [13]
RP   INTERACTION WITH RBMX.
RX   PubMed=19282290; DOI=10.1074/jbc.m901026200;
RA   Heinrich B., Zhang Z., Raitskin O., Hiller M., Benderska N., Hartmann A.M.,
RA   Bracco L., Elliott D., Ben-Ari S., Soreq H., Sperling J., Sperling R.,
RA   Stamm S.;
RT   "Heterogeneous nuclear ribonucleoprotein G regulates splice site selection
RT   by binding to CC(A/C)-rich regions in pre-mRNA.";
RL   J. Biol. Chem. 284:14303-14315(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142 AND TYR-153, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   PHOSPHORYLATION AT SER-34 AND THR-127, AND INTERACTION WITH AKT1.
RX   PubMed=20682768; DOI=10.1074/jbc.m110.122044;
RA   Nam S.Y., Seo H.H., Park H.S., An S., Kim J.Y., Yang K.H., Kim C.S.,
RA   Jeong M., Jin Y.W.;
RT   "Phosphorylation of CLK2 at serine 34 and threonine 127 by AKT controls
RT   cell survival after ionizing radiation.";
RL   J. Biol. Chem. 285:31157-31163(2010).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-98 AND SER-142, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=28289210; DOI=10.1073/pnas.1700082114;
RA   Kulkarni P., Jolly M.K., Jia D., Mooney S.M., Bhargava A., Kagohara L.T.,
RA   Chen Y., Hao P., He Y., Veltri R.W., Grishaev A., Weninger K., Levine H.,
RA   Orban J.;
RT   "Phosphorylation-induced conformational dynamics in an intrinsically
RT   disordered protein and potential role in phenotypic heterogeneity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 114:E2644-E2653(2017).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.89 ANGSTROMS) OF 135-496.
RG   Structural genomics consortium (SGC);
RT   "Structure of human cdc2-like kinase 2 (clk2).";
RL   Submitted (AUG-2010) to the PDB data bank.
CC   -!- FUNCTION: Dual specificity kinase acting on both serine/threonine and
CC       tyrosine-containing substrates. Phosphorylates serine- and arginine-
CC       rich (SR) proteins of the spliceosomal complex. May be a constituent of
CC       a network of regulatory mechanisms that enable SR proteins to control
CC       RNA splicing and can cause redistribution of SR proteins from speckles
CC       to a diffuse nucleoplasmic distribution. Acts as a suppressor of
CC       hepatic gluconeogenesis and glucose output by repressing PPARGC1A
CC       transcriptional activity on gluconeogenic genes via its
CC       phosphorylation. Phosphorylates PPP2R5B thereby stimulating the
CC       assembly of PP2A phosphatase with the PPP2R5B-AKT1 complex leading to
CC       dephosphorylation of AKT1. Phosphorylates: PTPN1, SRSF1 and SRSF3.
CC       Regulates the alternative splicing of tissue factor (F3) pre-mRNA in
CC       endothelial cells. Phosphorylates PAGE4 at several serine and threonine
CC       residues and this phosphorylation attenuates the ability of PAGE4 to
CC       potentiate the transcriptional activator activity of JUN
CC       (PubMed:28289210). {ECO:0000269|PubMed:10480872,
CC       ECO:0000269|PubMed:19168442, ECO:0000269|PubMed:28289210,
CC       ECO:0000269|PubMed:8910305, ECO:0000269|PubMed:9637771}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.12.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.12.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.12.1;
CC   -!- ACTIVITY REGULATION: 5,6-dichloro-1-b-D-ribofuranosylbenzimidazole
CC       (DRB) inhibits autophosphorylation. TG003 inhibits its kinase activity
CC       and affects the regulation of alternative splicing mediated by
CC       phosphorylation of SR proteins (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with RBMX. Interacts with AKT1 and UBL5.
CC       {ECO:0000269|PubMed:12705895, ECO:0000269|PubMed:19282290,
CC       ECO:0000269|PubMed:20682768}.
CC   -!- INTERACTION:
CC       P49760; Q9BZE9: ASPSCR1; NbExp=3; IntAct=EBI-750020, EBI-1993677;
CC       P49760; Q8WUQ7: CACTIN; NbExp=3; IntAct=EBI-750020, EBI-348479;
CC       P49760; Q8N2M8: CLASRP; NbExp=3; IntAct=EBI-750020, EBI-751069;
CC       P49760; P49759-3: CLK1; NbExp=5; IntAct=EBI-750020, EBI-11981867;
CC       P49760; P49760: CLK2; NbExp=6; IntAct=EBI-750020, EBI-750020;
CC       P49760; P49761: CLK3; NbExp=13; IntAct=EBI-750020, EBI-745579;
CC       P49760; Q8N684: CPSF7; NbExp=3; IntAct=EBI-750020, EBI-746909;
CC       P49760; Q96D03: DDIT4L; NbExp=3; IntAct=EBI-750020, EBI-742054;
CC       P49760; P42892: ECE1; NbExp=6; IntAct=EBI-750020, EBI-2859983;
CC       P49760; Q08426: EHHADH; NbExp=3; IntAct=EBI-750020, EBI-2339219;
CC       P49760; Q53SE7: FLJ13057; NbExp=3; IntAct=EBI-750020, EBI-10172181;
CC       P49760; Q9BX10: GTPBP2; NbExp=3; IntAct=EBI-750020, EBI-6115579;
CC       P49760; O95198: KLHL2; NbExp=6; IntAct=EBI-750020, EBI-746999;
CC       P49760; Q8TBB1: LNX1; NbExp=8; IntAct=EBI-750020, EBI-739832;
CC       P49760; Q9P127: LUZP4; NbExp=6; IntAct=EBI-750020, EBI-10198848;
CC       P49760; Q9BYD3: MRPL4; NbExp=3; IntAct=EBI-750020, EBI-721368;
CC       P49760; Q9UBU9: NXF1; NbExp=3; IntAct=EBI-750020, EBI-398874;
CC       P49760; P04553: PRM1; NbExp=3; IntAct=EBI-750020, EBI-13066730;
CC       P49760; Q8NAV1: PRPF38A; NbExp=3; IntAct=EBI-750020, EBI-715374;
CC       P49760; Q14498: RBM39; NbExp=9; IntAct=EBI-750020, EBI-395290;
CC       P49760; O76064: RNF8; NbExp=5; IntAct=EBI-750020, EBI-373337;
CC       P49760; D3DU92: RNPS1; NbExp=5; IntAct=EBI-750020, EBI-10176640;
CC       P49760; Q15287: RNPS1; NbExp=5; IntAct=EBI-750020, EBI-395959;
CC       P49760; Q9BUV0: RSRP1; NbExp=13; IntAct=EBI-750020, EBI-745604;
CC       P49760; O00560: SDCBP; NbExp=3; IntAct=EBI-750020, EBI-727004;
CC       P49760; Q8TAD8: SNIP1; NbExp=8; IntAct=EBI-750020, EBI-749336;
CC       P49760; P08621: SNRNP70; NbExp=5; IntAct=EBI-750020, EBI-1049228;
CC       P49760; P78362: SRPK2; NbExp=3; IntAct=EBI-750020, EBI-593303;
CC       P49760; Q8IYB3: SRRM1; NbExp=6; IntAct=EBI-750020, EBI-1055880;
CC       P49760; P84103: SRSF3; NbExp=3; IntAct=EBI-750020, EBI-372557;
CC       P49760; B2RWP4: TACC2; NbExp=3; IntAct=EBI-750020, EBI-14211313;
CC       P49760; P14373: TRIM27; NbExp=4; IntAct=EBI-750020, EBI-719493;
CC       P49760; Q86XT4: TRIM50; NbExp=3; IntAct=EBI-750020, EBI-9867283;
CC       P49760; Q01081-2: U2AF1; NbExp=3; IntAct=EBI-750020, EBI-10176676;
CC       P49760; Q7KZS0: UBE2I; NbExp=6; IntAct=EBI-750020, EBI-10180829;
CC       P49760; Q96MU7: YTHDC1; NbExp=6; IntAct=EBI-750020, EBI-2849854;
CC       P49760; P52737: ZNF136; NbExp=3; IntAct=EBI-750020, EBI-749129;
CC       P49760; O14978: ZNF263; NbExp=3; IntAct=EBI-750020, EBI-744493;
CC       P49760; Q96PQ6: ZNF317; NbExp=3; IntAct=EBI-750020, EBI-1210473;
CC       P49760; Q53GI3: ZNF394; NbExp=3; IntAct=EBI-750020, EBI-10211248;
CC       P49760; Q8TD17: ZNF398; NbExp=6; IntAct=EBI-750020, EBI-8643207;
CC       P49760; Q9C0F3: ZNF436; NbExp=3; IntAct=EBI-750020, EBI-8489702;
CC       P49760; Q8IYI8: ZNF440; NbExp=3; IntAct=EBI-750020, EBI-726439;
CC       P49760; Q8WTR7: ZNF473; NbExp=3; IntAct=EBI-750020, EBI-751409;
CC       P49760; Q8N8L2: ZNF491; NbExp=3; IntAct=EBI-750020, EBI-12019860;
CC       P49760; Q96NG5: ZNF558; NbExp=3; IntAct=EBI-750020, EBI-373363;
CC       P49760; Q96H86: ZNF764; NbExp=3; IntAct=EBI-750020, EBI-745775;
CC       P49760; Q9H5H4: ZNF768; NbExp=3; IntAct=EBI-750020, EBI-1210580;
CC       P49760; Q96EG3: ZNF837; NbExp=3; IntAct=EBI-750020, EBI-11962574;
CC       P49760; Q15696: ZRSR2; NbExp=8; IntAct=EBI-750020, EBI-6657923;
CC       P49760; Q9Y5A6: ZSCAN21; NbExp=5; IntAct=EBI-750020, EBI-10281938;
CC       P49760-3; A0A0S2Z4Z6: SRRM1; NbExp=3; IntAct=EBI-11535445, EBI-16438171;
CC       P49760-3; Q8IYB3: SRRM1; NbExp=3; IntAct=EBI-11535445, EBI-1055880;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:28289210}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Nucleus
CC       {ECO:0000269|PubMed:9637771}. Nucleus speckle
CC       {ECO:0000269|PubMed:9637771}. Note=Inhibition of phosphorylation at
CC       Ser-142 results in accumulation in the nuclear speckle.
CC       {ECO:0000250|UniProtKB:O35491}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Nucleus speckle
CC       {ECO:0000269|PubMed:9637771}. Note=Co-localizes with serine- and
CC       arginine-rich (SR) proteins in the nuclear speckles.
CC       {ECO:0000269|PubMed:9637771}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Long;
CC         IsoId=P49760-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=P49760-2; Sequence=VSP_004856, VSP_004857;
CC       Name=3;
CC         IsoId=P49760-3; Sequence=VSP_038744;
CC   -!- TISSUE SPECIFICITY: Endothelial cells (PubMed:19168442). Expressed in
CC       androgen-dependent prostate cancer cells (PubMed:28289210).
CC       {ECO:0000269|PubMed:19168442, ECO:0000269|PubMed:28289210}.
CC   -!- PTM: Autophosphorylates on all three types of residues. Phosphorylation
CC       on Ser-34 and Thr-127 by AKT1 is induced by ionizing radiation or
CC       insulin. Phosphorylation plays a critical role in cell proliferation
CC       following low dose radiation and prevents cell death following high
CC       dose radiation. Phosphorylation at Thr-344 by PKB/AKT2 induces its
CC       kinase activity which is required for its stability. The
CC       phosphorylation status at Ser-142 influences its subnuclear
CC       localization; inhibition of phosphorylation at Ser-142 results in
CC       accumulation in the nuclear speckle. {ECO:0000269|PubMed:20682768,
CC       ECO:0000269|PubMed:9637771}.
CC   -!- MISCELLANEOUS: [Isoform 2]: Lacks the kinase domain. May be produced at
CC       very low levels due to a premature stop codon in the mRNA, leading to
CC       nonsense-mediated mRNA decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr
CC       protein kinase family. Lammer subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L29218; AAA61482.1; -; mRNA.
DR   EMBL; L29216; AAA61481.1; -; mRNA.
DR   EMBL; AF023268; AAC51817.1; -; Genomic_DNA.
DR   EMBL; AL713999; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC014067; AAH14067.1; -; mRNA.
DR   EMBL; BC053603; AAH53603.1; -; mRNA.
DR   CCDS; CCDS1107.1; -. [P49760-3]
DR   CCDS; CCDS72939.1; -. [P49760-1]
DR   PIR; S53637; S53637.
DR   PIR; S53638; S53638.
DR   RefSeq; NP_001281267.1; NM_001294338.1. [P49760-1]
DR   RefSeq; NP_001281268.1; NM_001294339.1.
DR   RefSeq; NP_003984.2; NM_003993.3. [P49760-3]
DR   PDB; 3NR9; X-ray; 2.89 A; A/B/C=135-496.
DR   PDB; 5UNP; X-ray; 2.92 A; A/B=129-496.
DR   PDB; 6FYI; X-ray; 2.60 A; A=132-496.
DR   PDB; 6FYK; X-ray; 2.39 A; A/B/C=136-496.
DR   PDB; 6FYL; X-ray; 1.95 A; A=136-496.
DR   PDB; 6KHE; X-ray; 2.80 A; A=1-499.
DR   PDBsum; 3NR9; -.
DR   PDBsum; 5UNP; -.
DR   PDBsum; 6FYI; -.
DR   PDBsum; 6FYK; -.
DR   PDBsum; 6FYL; -.
DR   PDBsum; 6KHE; -.
DR   AlphaFoldDB; P49760; -.
DR   SMR; P49760; -.
DR   BioGRID; 107607; 174.
DR   DIP; DIP-42277N; -.
DR   IntAct; P49760; 140.
DR   MINT; P49760; -.
DR   STRING; 9606.ENSP00000357345; -.
DR   BindingDB; P49760; -.
DR   ChEMBL; CHEMBL4225; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; P49760; -.
DR   GuidetoPHARMACOLOGY; 1991; -.
DR   iPTMnet; P49760; -.
DR   PhosphoSitePlus; P49760; -.
DR   BioMuta; CLK2; -.
DR   DMDM; 1705919; -.
DR   EPD; P49760; -.
DR   jPOST; P49760; -.
DR   MassIVE; P49760; -.
DR   MaxQB; P49760; -.
DR   PaxDb; P49760; -.
DR   PeptideAtlas; P49760; -.
DR   PRIDE; P49760; -.
DR   ProteomicsDB; 56093; -. [P49760-1]
DR   ProteomicsDB; 56094; -. [P49760-2]
DR   ProteomicsDB; 56095; -. [P49760-3]
DR   Antibodypedia; 34187; 327 antibodies from 30 providers.
DR   DNASU; 1196; -.
DR   Ensembl; ENST00000361168.9; ENSP00000354856.5; ENSG00000176444.19. [P49760-3]
DR   Ensembl; ENST00000368361.9; ENSP00000357345.4; ENSG00000176444.19. [P49760-1]
DR   Ensembl; ENST00000572269.5; ENSP00000459461.1; ENSG00000261893.5. [P49760-3]
DR   Ensembl; ENST00000574445.5; ENSP00000460443.1; ENSG00000261893.5. [P49760-1]
DR   GeneID; 1196; -.
DR   KEGG; hsa:1196; -.
DR   MANE-Select; ENST00000368361.9; ENSP00000357345.4; NM_001294338.2; NP_001281267.1.
DR   UCSC; uc001fjw.4; human. [P49760-1]
DR   CTD; 1196; -.
DR   DisGeNET; 1196; -.
DR   GeneCards; CLK2; -.
DR   HGNC; HGNC:2069; CLK2.
DR   HPA; ENSG00000176444; Low tissue specificity.
DR   MIM; 602989; gene.
DR   neXtProt; NX_P49760; -.
DR   OpenTargets; ENSG00000176444; -.
DR   PharmGKB; PA26595; -.
DR   VEuPathDB; HostDB:ENSG00000176444; -.
DR   eggNOG; KOG0671; Eukaryota.
DR   GeneTree; ENSGT00940000154947; -.
DR   InParanoid; P49760; -.
DR   OMA; CIVFEYY; -.
DR   PhylomeDB; P49760; -.
DR   TreeFam; TF101041; -.
DR   BRENDA; 2.7.12.1; 2681.
DR   PathwayCommons; P49760; -.
DR   SignaLink; P49760; -.
DR   SIGNOR; P49760; -.
DR   BioGRID-ORCS; 1196; 107 hits in 1109 CRISPR screens.
DR   ChiTaRS; CLK2; human.
DR   EvolutionaryTrace; P49760; -.
DR   GeneWiki; CLK2; -.
DR   GenomeRNAi; 1196; -.
DR   Pharos; P49760; Tchem.
DR   PRO; PR:P49760; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P49760; protein.
DR   Bgee; ENSG00000176444; Expressed in right uterine tube and 94 other tissues.
DR   ExpressionAtlas; P49760; baseline and differential.
DR   Genevisible; P49760; HS.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0045721; P:negative regulation of gluconeogenesis; ISS:UniProtKB.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IBA:GO_Central.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0043484; P:regulation of RNA splicing; IDA:UniProtKB.
DR   GO; GO:0010212; P:response to ionizing radiation; IMP:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Kinase;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Tyrosine-protein kinase.
FT   CHAIN           1..499
FT                   /note="Dual specificity protein kinase CLK2"
FT                   /id="PRO_0000085868"
FT   DOMAIN          163..479
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..67
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          101..143
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..18
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        19..34
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        35..67
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        112..129
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        290
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         169..177
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         193
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         34
FT                   /note="Phosphoserine; by PKB/AKT1"
FT                   /evidence="ECO:0000269|PubMed:20682768"
FT   MOD_RES         98
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         99
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:O35491"
FT   MOD_RES         127
FT                   /note="Phosphothreonine; by PKB/AKT1"
FT                   /evidence="ECO:0000269|PubMed:20682768"
FT   MOD_RES         142
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:18691976, ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         153
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:19369195"
FT   MOD_RES         344
FT                   /note="Phosphothreonine; by PKB/AKT2"
FT                   /evidence="ECO:0000250|UniProtKB:O35491"
FT   VAR_SEQ         134..139
FT                   /note="QHSSRR -> MKSLAP (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:7990150"
FT                   /id="VSP_004856"
FT   VAR_SEQ         134
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_038744"
FT   VAR_SEQ         140..499
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:7990150"
FT                   /id="VSP_004857"
FT   STRAND          142..144
FT                   /evidence="ECO:0007829|PDB:6FYK"
FT   TURN            146..149
FT                   /evidence="ECO:0007829|PDB:6FYK"
FT   TURN            160..162
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   STRAND          163..171
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   STRAND          173..182
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   TURN            183..187
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   STRAND          189..195
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   HELIX           199..218
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   STRAND          224..226
FT                   /evidence="ECO:0007829|PDB:6FYK"
FT   STRAND          229..235
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   STRAND          238..244
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   HELIX           250..256
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   TURN            257..259
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   HELIX           264..283
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   HELIX           293..295
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   STRAND          296..299
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   STRAND          303..308
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   TURN            309..312
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   STRAND          313..319
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   STRAND          323..325
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   HELIX           328..330
FT                   /evidence="ECO:0007829|PDB:6KHE"
FT   STRAND          332..336
FT                   /evidence="ECO:0007829|PDB:3NR9"
FT   HELIX           345..347
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   HELIX           350..353
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   HELIX           361..376
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   HELIX           386..397
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   HELIX           402..407
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   HELIX           411..413
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   STRAND          423..425
FT                   /evidence="ECO:0007829|PDB:6KHE"
FT   HELIX           426..434
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   HELIX           438..441
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   HELIX           447..459
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   TURN            464..466
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   HELIX           470..473
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   HELIX           477..479
FT                   /evidence="ECO:0007829|PDB:6FYL"
FT   HELIX           480..483
FT                   /evidence="ECO:0007829|PDB:3NR9"
SQ   SEQUENCE   499 AA;  60090 MW;  E43BBF3BAD6EF991 CRC64;
     MPHPRRYHSS ERGSRGSYRE HYRSRKHKRR RSRSWSSSSD RTRRRRREDS YHVRSRSSYD
     DRSSDRRVYD RRYCGSYRRN DYSRDRGDAY YDTDYRHSYE YQRENSSYRS QRSSRRKHRR
     RRRRSRTFSR SSSQHSSRRA KSVEDDAEGH LIYHVGDWLQ ERYEIVSTLG EGTFGRVVQC
     VDHRRGGARV ALKIIKNVEK YKEAARLEIN VLEKINEKDP DNKNLCVQMF DWFDYHGHMC
     ISFELLGLST FDFLKDNNYL PYPIHQVRHM AFQLCQAVKF LHDNKLTHTD LKPENILFVN
     SDYELTYNLE KKRDERSVKS TAVRVVDFGS ATFDHEHHST IVSTRHYRAP EVILELGWSQ
     PCDVWSIGCI IFEYYVGFTL FQTHDNREHL AMMERILGPI PSRMIRKTRK QKYFYRGRLD
     WDENTSAGRY VRENCKPLRR YLTSEAEEHH QLFDLIESML EYEPAKRLTL GEALQHPFFA
     RLRAEPPNKL WDSSRDISR
//
